Gardere’s international trade team, in partnership with financial advisory firm GlassRatner, co-hosted a “spooky” half-day seminar on Foreign Corrupt Practices Act (FCPA) compliance and enforcement at the Firm’s new Dallas office in Uptown.
Compliance counsel from a diverse group of industries provided practical insights and best practices on the real-life application of the FCPA in the U.S. and abroad. An enforcement attorney from the SEC also shared expectations on compliance and monitoring.
Speakers included Akita Adkins from the Securities and Exchange Commission’s FCPA Unit, along with compliance professionals from Baker Hughes, BBA Aviation, DynCorp International, Fluor, Gruma Corporation, Hewlett-Packard and Mary Kay Inc.
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.